samedan logo
 
 
spacer
home > directory > Richter Helm
PHARMACEUTICAL INDUSTRY DIRECTORY

Richter Helm

With Richter-Helm BioLogics and Richter-Helm BioTec over 20 years of experience in the fast growing science of biotechnology and the innovative strength of high-performance teams are coupled with the solid foundation of the owner companies Gedeon Richter Plc., Hungary and Helm AG, Germany.  Richter-Helm BioLogics, formerly known as Strathmann Biotec, offers services for the development and manufacture of biopharmaceutical products from customers in the pharmaceutical and biotechnology industries. Richter-Helm BioLogics produces recombinant proteins, plasmid DNA and vaccines in microbial systems. Richter-Helm BioTec is responsible for business development, marketing & sales activities and the management of product developments not only for their own pipeline but also for joint venture development work in collaboration with associate companies. In order to enlarge the product pipeline Richter-Helm BioTec is actively seeking for further development projects at all stages. Richter-Helm BioTec can be considered as the often missing link between biotech companies and the pharmaceutical industry. The world wide presence allows the company to fully exploit the market potential of the products on a global basis.

Thanks to our years of experience with protein expression systems, plasmid DNA technologies, downstream processes and cGMP manufacturing, we are in a position to offer our customers and business partners a first-class service from the development through to the production stage. Our development services comprise the establishment of production strains as well as the development of fermentation and downstream processes for manufacturing of recombinant proteins and plasmid DNA. In our state-of-the-art cGMP production facilities we set up cell banks (MCB and WCB) and produce biopharmaceuticals, both for clinical trials and market supplies.

Your contact address for all questions and enquiries concerning the contract development, contract manufacturing services and business development is Richter-Helm BioTec.

Products and Services

The teams at Richter-Helm have excellent expertise in the development and production of biopharmaceuticals. This knowledge, combined with highest quality standards according to current regulatory requirements is the best recommendation for reliable and successful co-operations. Richter-Helm offers to its customers a full range of biopharmaceutical services like:

 Production of Recombinant Proteins

– Development of production strains (E. coli, yeast)
– Optimisation of expression in different systems
– Establishment of MCB/WCB
– Development of the fermentation (10 to 1,000 litres) and down stream processes
– Development of analytical methods including bioassay development
– Validation of analytical methods
– cGMP manufacturing for clinical phase I to III
– cGMP commercial manufacturing
– Process validation
– In-house QC testing and release
– Stability studies according to ICH

 Production of Plasmid DNA

– Development of production strains
– Establishment of MCB/WCB
– Development of the fermentation (10 to 1,000 litres) and down stream process
– Development of analytical methods
– cGMP manufacturing for clinical phase I to III
– cGMP commercial manufacturing
– In-house QC testing and release

Production of Vaccines

Richter-Helm has long lasting experience in the development and manufacturing of microbial vaccines. 

Partnering and Licensing

Richter-Helm BioTec is evaluating new development projects to enlarge their own development pipeline and is offering license opportunities for co-development and marketing of biopharmaceutical products.

+49(0)40-2375-0
www.richter-helm.eu/
Nordkanalstr. 28, 20097 Hamburg
 
Print this page
Send to a friend
spacer

Member login

E-mail address:

Password:
Remember me

Industry Events

Exploratory Clinical Development World Americas 2008

23-25 September 2008, Philadelphia Marriott Downtown, 1201 Market Street, Philadelphia, Pennsylvania, 19107 USA

Following on from the huge success of the Exploratory Clinical Development World Europe, the Americas congress will give you a critical insight into the latest strategies on how the industry is addressing and elevating the current challenges in early clinical development.
More info >>

 
News and Press Releases

Azopharma Product Development Group, Inc

HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >>

 
©2000-2007 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement